New markers in Parkinson's disease.

Area of Science:

• Neuroscience
• Biochemistry
• Genetics
• Radiology

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder with significant motor and non-motor symptoms.
• Current diagnostic tools for PD are limited, hindering effective risk prediction, diagnosis, and management.
• There is a critical need for reliable biomarkers to predict PD risk and monitor disease progression.

Purpose of the Study:

• To review recent advancements in serial biomarkers for Parkinson's disease.
• To explore diverse biomarker sources including clinical, biochemical, genetic, and neuroimaging data.
• To highlight the potential of multi-modal biomarker approaches for PD management.

Main Methods:

• Literature review focusing on recent developments in Parkinson's disease biomarkers.
• Analysis of clinical, biochemical, genetic, and neuroimaging data relevant to PD.
• Synthesis of findings on the utility of serial biomarkers for disease tracking.

Main Results:

• No single reliable biomarker currently exists for predicting motor and cognitive decline in PD.
• Longitudinal studies on PD temporal progression are scarce.
• A combination of multiple biomarkers may enhance early diagnosis and prognosis accuracy.

Conclusions:

• Developing reliable biomarkers is a high priority in Parkinson's disease research.
• Serial biomarkers from various perspectives (clinical, biochemical, genetic, neuroimaging) are crucial.
• Multi-biomarker strategies offer a promising avenue for improved PD diagnosis and prognosis.